Publication | Closed Access

RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineImmunologyBiomarkersNeurochemical BiomarkersAutoantibodiesNeurologyImmune FunctionNeurodegenerationAging-associated DiseaseNeuroimmunologyNeuroinflammation